ARAF and familial pancreatic carcinoma: Recent studies have indicated that ARAF required for MAPK activation enhances the migration and invasive ability of various cancer types, such as colon cancer, pancreatic cancer and breast cancers (Lee et al., 2010; Mooz et al., 2014).